ReviewCurrent genomics2025
The Role of Collagen Genetic Variability in Degenerative Disc Disease and Related Conditions.
Review in Current genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Degenerative Disc Disease (DDD) and related musculoskeletal disorders depend heavily on the structural integrity of collagen in the Extracellular Matrix (ECM) of connective tissues. The roles of collagen types I, II, IX, and XI in Intervertebral Disc (IVD) dynamics have been previously examined. Genetic polymorphisms in collagen-encoding genes are associated with susceptibility to DDD. These polymorphisms influence the quality and arrangement of collagen fibrils, thereby affecting the overall health of the connective tissues. CRISPR/Cas9 offers a viable method for correcting pathogenic genetic variants associated with collagen-related pathologies. This review also emphasizes the need for a deeper understanding of gene-environment interactions, which is critical for the development of personalized medicine for the treatment and management of DDD and related conditions. Expanding genetic studies and integrating insights into biomaterials and tissue engineering are essential for this purpose. A comprehensive genetic approach promises advances in predictive, preventive, and personalized health care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.